Enfermedades Infecciosas

Alonso, R; Perez-Garcia, F; Gijon, P; Collazos, A; Bouza, E.

Evaluation of the Architect HIV Ag/Ab Combo Assay in a low-prevalence setting: The role of samples with a low S/CO ratio

JOURNAL OF CLINICAL VIROLOGY. 2018; 103: 43-47 Nº de citas: 16 [doi:10.1016/j.jcv.2018.04.002]

Oviano, M; Rodriguez-Sanchez, B; Gomara, M; Alcala, L; Zvezdanova, E; Ruiz, A; Velasco, D; Gude, MJ; Bouza, E; Bou, G.

Direct identification of clinical pathogens from liquid culture media by MALDI-TOF MS analysis

CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(6): 624-629 Nº de citas: 13 [doi:10.1016/j.cmi.2017.09.010]

Guembe, M; Perez-Granda, MJ; Capdevila, JA; Barberan, J; Pinilla, B; Bouza, E.

Impact of a training program on adherence to recommendations for care of venous lines in internal medicine departments in Spain

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2018; 37(6): 1163-1168 Nº de citas: 9 [doi:10.1007/s10096-018-3236-4]

Guembe, M; Alonso, B; Lucio, J; Perez-Granda, MJ; Cruces, R; Sanchez-Carrillo, C; Fernandez-Cruz, A; Bouza, E.

Biofilm production is not associated with poor clinical outcome in 485 patients with Staphylococcus aureus bacteraemia

CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(6): Nº de citas: 19 [doi:10.1016/j.cmi.2017.10.018]

Ullmann, AJ; Aguado, JM; Arikan-Akdagli, S; Denning, DW; Groll, AH; Lagrou, K; Lass-Florl, C; Lewis, RE; Munoz, P; Verweij, PE; Warris, A; Ader, F; Akova, M; Arendrup, MC; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Bruggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cuenca-Estrella, M; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lange, C; Lehrnbecher, T; Loffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinko, J; Skiada, A; Vehreschild, MJGT; Viscoli, C; Cornely, OA.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24: 1-38 Nº de citas: 945 [doi:10.1016/j.cmi.2018.01.002]

Di Domenico, EG; Cavallo, I; Guembe, M; Prignano, G; Gallo, MT; Bordignon, V; D'Agosto, G; Sperduti, I; Toma, L; Ensoli, F.

The clinical Biofilm Ring Test: a promising tool for the clinical assessment of biofilm-producing Candida species

FEMS YEAST RESEARCH. 2018; 18(3): Nº de citas: 8 [doi:10.1093/femsyr/foy025]

Bartoletti, M; Giannella, M; Lewis, R; Caraceni, P; Tedeschi, S; Paul, M; Schramm, C; Bruns, T; Merli, M; Cobos-Trigueros, N; Seminari, E; Retamar, P; Munoz, P; Tumbarello, M; Burra, P; Cerenzia, MT; Barsic, B; Calbo, E; Maraolo, AE; Petrosillo, N; Galan-Ladero, MA; D'Offizi, G; Bar Sinai, N; Rodriguez-Bano, J; Verucchi, G; Bernardi, M; Viale, P; ESGBIS BICHROME Study Grp.

A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients

CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(5): Nº de citas: 78 [doi:10.1016/j.cmi.2017.08.001]

Canton, R; Loza, E; Aznar, J; Barron-Aduriz, R; Calvo, J; Castillo, FJ; Cercenado, E; Cisterna, R; Gonzalez-Romo, F; Lopez-Hontangas, JL; Suarez-Barrenechea, AI; Tubau, F; Molloy, B; Lopez-Mendoza, D.

Antimicrobial susceptibility trends and evolution of isolates with extended spectrum beta-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015)

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2018; 31(2): 136-145 Nº de citas: 9

Bouza, E; Valerio, M; Soriano, A; Morata, L; Carus, EG; Rodriguez-Gonzalez, C; Hidalgo-Tenorio, MC; Plata, A; Munoz, P; Vena, A.

Dalbavancin in the treatment of different gram-positive infections: a real-life experience

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2018; 51(4): 571-577 Nº de citas: 140 [doi:10.1016/j.ijantimicag.2017.11.008]

Coll, P; de Viedma, DG.

Molecular epidemiology of tuberculosis

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018; 36(4): 233-240 Nº de citas: 9 [doi:10.1016/j.eimc.2018.01.001]

Gutierrez-Pizarraya, A; Martin-Villen, L; Alcala-Hernandez, L; Arriaza, MM; Balandin-Moreno, B; Aragon-Gonzalez, C; Ferreres-Franco, J; Monleon, MAC; Anguita-Alonso, P; Bouza-Santiago, E; Garnacho-Montero, J.

Epidemiology and risk factors for Clostridium difficile infection in critically ill patients in Spain: The PROCRID study

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018; 36(4): 218-221 Nº de citas: 5 [doi:10.1016/j.eimc.2017.01.007]

Reigadas, E; Alcala, L; Gomez, J; Marin, M; Martin, A; Onori, R; Munoz, P; Bouza, E.

Breakthrough Clostridium difficile Infection in Cirrhotic Patients Receiving Rifaximin

CLINICAL INFECTIOUS DISEASES. 2018; 66(7): 1086-1091 Nº de citas: 24 [doi:10.1093/cid/cix918]

Espinel-Ingroff, A; Turnidge, J; Alastruey-Izquierdo, A; Dannaoui, E; Garcia-Effron, G; Guinea, J; Kidd, S; Pelaez, T; Sanguinetti, M; Meletiadis, J; Botterel, F; Bustamante, B; Chen, YC; Chakrabarti, A; Chowdhary, A; Chryssanthou, E; Cordoba, S; Gonzalez, GM; Guarro, J; Johnson, EM; Kus, JV; Lass-Florl, C; Linares-Sicilia, MJ; Martin-Mazuelos, E; Negri, CE; Pfaller, MA; Tortorano, AM.

Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2018; 62(4): Nº de citas: 37 [doi:10.1128/AAC.01916-17]

Bouza, E; Munoz, P; Burillo, A.

The role of tedizolid in skin and soft tissue infections

CURRENT OPINION IN INFECTIOUS DISEASES. 2018; 31(2): 131-140 Nº de citas: 14 [doi:10.1097/QCO.0000000000000439]

Rivoisy, C; Vena, A; Schaeffer, L; Charlier, C; Fontanet, A; Delahaye, F; Bouza, E; Lortholary, O; Munoz, P; Lefort, A; French Mycoses Study Grp; Grp Apoyo Manejo Endocarditis Espa.

Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study

CLINICAL INFECTIOUS DISEASES. 2018; 66(6): 825-832 Nº de citas: 50 [doi:10.1093/cid/cix913]

Alonso B; Cruces R; Perez A; Fernandez-Cruz A; Guembe M.

Activity of maltodextrin and vancomycin against staphylococcus aureus biofilm.

Frontiers in Bioscience - Scholar. 2018; 10: 300-308

Munoz, P; Vena, A; Machado, M; Martinez-Jimenez, MC; Gioia, F; Gomez, E; Origuen, J; Orellana, MA; Lopez-Medrano, F; Perez-Granda, MJ; Aguado, JPM; Fortun, J; Bouza, E.

T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018; 73: 13-19 Nº de citas: 25 [doi:10.1093/jac/dky048]

Munoz, P; Vena, A; Machado, M; Gioia, F; Martinez-Jimenez, MC; Gomez, E; Origuen, J; Orellana, MA; Lopez-Medrano, F; Fernandez-Ruiz, M; Merino, P; Gonzalez-Romo, F; Frias, I; Perez-Granda, MJ; Aguado, JM; Fortun, J; Bouza, E.

T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018; 73: 6-12 Nº de citas: 50 [doi:10.1093/jac/dky047]